NAL Pharma
NAL Pharma is a specialty biopharmaceutical company that develops proprietary drug delivery systems and manufactures robust products to help treat patients around the world.
Industries
Nr. of Employees
small (1-50)
NAL Pharma
Causeway Bay, Hong Kong Island, Hong Kong, Asia
Products
Extended‑release depot formulations (weekly to quarterly)
Long‑acting formulations designed to deliver therapeutics over 1 week, 1 month, or 3 months for indications such as oncology.
Nanoparticle injectable controlled‑release formulations
Injectable formulations using liposome encapsulation or albumin‑bound approaches to extend half‑life and control release.
Transdermal target‑delivery formulations
Transdermal formulations employing skin penetration enhancers to enable targeted dermal or systemic delivery.
Orally dissolving film (ODF) products
Films formulated for rapid dissolution in the oral cavity to enable sublingual or buccal absorption.
Oral controlled‑release formulations with API form control
Oral controlled‑release dosage forms developed alongside control or selection of API crystalline forms to modulate release.
Extended‑release depot formulations (weekly to quarterly)
Long‑acting formulations designed to deliver therapeutics over 1 week, 1 month, or 3 months for indications such as oncology.
Nanoparticle injectable controlled‑release formulations
Injectable formulations using liposome encapsulation or albumin‑bound approaches to extend half‑life and control release.
Transdermal target‑delivery formulations
Transdermal formulations employing skin penetration enhancers to enable targeted dermal or systemic delivery.
Orally dissolving film (ODF) products
Films formulated for rapid dissolution in the oral cavity to enable sublingual or buccal absorption.
Oral controlled‑release formulations with API form control
Oral controlled‑release dosage forms developed alongside control or selection of API crystalline forms to modulate release.
Services
Out‑licensing of pharmaceutical formulations and technologies
Licensing of developed drug delivery formulations and associated technology to external pharmaceutical or biotech partners.
Out‑licensing of pharmaceutical formulations and technologies
Licensing of developed drug delivery formulations and associated technology to external pharmaceutical or biotech partners.
Expertise Areas
- Drug delivery system development
- Controlled‑release and depot formulations
- Nanoparticle injectable formulations
- Transdermal delivery
Key Technologies
- Liposome encapsulation
- Albumin‑bound nanoparticle formulation
- Nanoparticle controlled‑release
- Transdermal delivery with permeation enhancers